神经保护
神经炎症
脑出血
组织蛋白酶C
医学
组织蛋白酶D
体内
癌症研究
药理学
免疫学
基因剔除小鼠
组织蛋白酶B
小胶质细胞
血脑屏障
神经科学
戊地昔布
体外
病态的
生物信息学
免疫系统
虚拟筛选
炎症
组织蛋白酶K
细胞外
化学
脑损伤
趋化因子
中性粒细胞胞外陷阱
作者
Junjun Meng,Jianhua Wang,Tao Zhang,Xiaofan Fan,Jinxiu Guo,Shiyuan Zhao,Wenxue Sun,Pei Jiang
摘要
Intracerebral hemorrhage (ICH) is a devastating neurological disorder with high mortality and disability, where neuroinflammation-driven secondary brain injury is a key pathological hallmark. Neutrophil extracellular traps (NETs) serve as critical pathogenic mediators that amplify neuroinflammation, disrupt blood-brain barrier integrity, and exacerbate brain damage after ICH. This study identifies Efoba, a novel bioactive monomer from aged garlic, and establishes a scalable total‑synthesis route for hundred‑gram‑scale high‑purity production, overcoming low‑yield and supply‑limiting bottlenecks for natural product research. In vivo and in vitro experiments show Efoba markedly ameliorates ICH‑induced neurological impairments and inhibits NET formation. Integrative analyses (Lip-MS, virtual screening, proteomics, transcriptomics) identified cathepsin C (CTSC) as the direct binding target of Efoba. Efoba stabilizes microglial lysosomal membranes, inhibits CTSC release, blocks NET generation, and exerts neuroprotection against NETs-driven neuroinflammation. CTSC knockout and CTSC overexpression assays further confirm the indispensable role of CTSC in mediating Efoba's neuroprotective and anti‑inflammatory activities. Collectively, this work demonstrates for the first time that Efoba targets CTSC to suppress NET-mediated neuroinflammation, highlighting its therapeutic potential and the translational value of natural active components.
科研通智能强力驱动
Strongly Powered by AbleSci AI